Saturday, March 30, 2013

Reuters: Health News: Lonza CEO says reviewing biosimilar venture with Teva

Lonza CEO says reviewing biosimilar venture with Teva

ZURICH (Reuters) - Swiss specialty chemicals and life sciences group Lonza is reviewing whether it is still worth investing in its joint venture with ...

Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/HnT1Xu5NkSQ/story01.htm


No comments:

Post a Comment

Subscribe Now: Feed Icon